Arrange comprehensive data review / discuss pilot study
Please call Matt Shipton at (732) 253-0295
or email mshipton@hurelcorp.com

Alternatively, please fill out the form below and we will contact you.

your name: *
your phone: *
your email: *
optional information:
I am especially interested in:
 selected HµRELhumanTM single-donor hepatic model
 selected HµRELhumanPoolTM pooled platable hepatic model
 selected non-human species hepatic models: HµRELcanineTM, HµRELratTM, HµRELprimateTM
 selected ACEA-HµREL® integrated 7-day continuous hepatotoxicity profile
 selected HµRELflowTM microfluidic model
your organization:
your department:
your job title:
your area(s) of research:
anything you wish to tell us about your research objectives or reason(s) for your interest in HµREL®:
* required

HµRELToxTM
multi-readout, repeat-dose
DILI screening
DILI screening

Hurel microlivers afford better prediction than 3D

Toxicology Research
HµRELviralTM
Long-enduring infectious liver disease platform
Time-Based
Toxicity Ratios*
A new marker for hepatotoxic chronicity

TAAP
*patent pending
HµRELfluxTM
a new, patent-pending
efflux transport
assay method
DMPK
Superior intrinsic clearance
and biotransformation of
low-turnover drugs

DMD